Sanofi, GSK to gracefully up to 60 million dosages of COVID-19 antibody to UK Kumar Jeetendra | July 29, 2020 Sanofi And GSK said they had reached a deal with Britain to provide it with as much as 60 million doses of an expected COVID-19 vaccine, and that discussions with different authorities were ongoing. No Vaccine has been prescribed to treat or protect against COVID-19, the respiratory disorder caused by the new coronavirus which has …
US to pay $2.1 billion to Sanofi, GSK in COVID-19 antibody bargain Kumar Jeetendra | July 31, 2020 The US government will pay $2.1 billion to Sanofi SA and GlaxoSmithKline Plc to get COVID-19 vaccines to pay 50 million individuals and to underwrite the drug manufacturers’ testing and manufacturing, the companies said on Friday. The award is the biggest yet from’Operation Warp Speed’, the White House initiative aimed at accelerating access to treatments …
Zydus Cadila gets USFDA gesture for muscle relaxant infusion Kumar Jeetendra | September 2, 2020 Zydus Cadila has obtained final acceptance by the US Food and Drug Administration (USFDA) to advertise Cisatracurium Besylate Injection USP at the potency of 20 milligrams (base)/10 mL (two mg/mL) multiple-dose vial, Cadila Healthcare stated in a regulatory filing on Wednesday. The drug will be produced in Liva plant of Cadila Healthcare Ltd.. Zydus Cadila …
Zydus Cadila gets USFDA gesture to showcase its disease treatment infusion Kumar Jeetendra | September 11, 2020 New Delhi, Sep 11 (PTI) Medication firm Zydus Cadila on Friday said it has received final nod in the US health regulator to advertise its generic Doxorubicin Hydrochloride Liposome injection, used for treatment of certain types of cancer, in the American market. The company has received final approval from the United States Food and Drug …
India preliminaries for Russia’s ‘Sputnik-V’ antibody may start in next barely any weeks: Dr Reddy’s Kumar Jeetendra | September 22, 2020 Reddy’s Laboratories Ltd could start late-stage Indian clinical trials of Russia’s potential coronavirus vaccine within the next few months, an executive in the Indian drugmaker said on Tuesday. Indian trials of this Sputnik-V vaccine candidate, being developed by Russia’s sovereign wealth fund, will enroll 1,000-2,000 participants and also be conducted at multiple private and government …
FDA endorsed drug ‘Teicoplanin’ discovered more powerful in treating COVID – 19 infection: IIT Delhi research Kumar Jeetendra | September 28, 2020 Clinically approved drug”Teicoplanin” is a potential therapeutic alternative against COVID-19 and may be ten times more effective than many drugs being currently used, a study by Indian Institute of Technology (IIT), Delhi has found. The research from the institute’s Kusuma School of Biological Science screened an assemblage of 23 approved drugs, which have shown leads …
Rhizen Pharma gets USFDA endorsement for stage one clinical preliminaries for Covid-19 drug Kumar Jeetendra | December 3, 2020 New Delhi, Dec 2 (PTI) Rhizen Pharmaceuticals, a member firm of Alembic Pharmaceuticals, on Wednesday said it has received approval from the US health regulator to commence phase one clinical trials on retroviral oral drug for the treatment of COVID-19. The Switzerland-based firm, which will be a clinical-stage oncology-focussed biopharmaceutical company, has obtained approval for …
WHO says specialists examining new COVID-19 variant in England Kumar Jeetendra | December 15, 2020 Myth 1: Mental illnesses are rare | On October 7, the World Health Organization said “close to one billion people globally have a mental disorder”. (Image: Reuters) The World Health Organization is aware of a new variant of COVID-19 that has emerged in Britain, but there is no evidence the strain behaves differently to existing …
Cipla Launches ‘CIPtest’ Rapid Antigen Detection Test for COVID-19 Diagnosis Kumar Jeetendra | December 16, 2020 Mumbai, India; December 16, 2020: Cipla Limited (BSE: 500087; NSE: CIPLA EQ) referred to as “Cipla” today announced its partnership with the Premier Medical Corporation Private Limited for commercialisation of the rapid antigen test kits for COVID-19 in India. The company will commence supply from this week. This is Cipla’s second launch in the diagnostics …
Johnson and Johnson says in talks with Indian government for preliminary of single-portion vaccine Kumar Jeetendra | April 9, 2021 Johnson & Johnson is in talks with India’s government to start a clinical trial of its single-dose COVID-19 vaccine in the country, the company said on Friday. The U.S. drugs and health care giant’s vaccine is currently approved for use in the USA, the European Union and other countries including Thailand and South Africa. The …
Caplin Point Laboratories arm gets USFDA gesture for Neostigmine Methylsulfate Injection Kumar Jeetendra | April 22, 2021 New Delhi: Caplin Point Laboratories on Thursday said its subsidiary has received approval from the US health regulator for Neostigmine Methylsulfate Injection. Neostigmine Methylsulfate Injection is a cholinesterase inhibitor and is indicated for the reversal of the effects of non-depolariSing neuromuscular blocking agents (NMBAs) after surgery. “Caplin Steriles Ltd (Caplin) has been granted final approval …
Cipla enters into a licensing agreement with MSD to expand access to investigational oral therapeutic drug for COVID-19 treatment Kumar Jeetendra | April 28, 2021 Mumbai, India; April 28, 2021: Cipla Limited (BSE: 500087; NSE: CIPLA EQ; and hereafter referred to as “Cipla”) today announced that it has signed a non-exclusive licensing agreement with MSD a tradename of Merck & Co., Inc. Kenilworth, NJ., USA for the manufacturing and distribution of Molnupiravir, the investigational oral antiviral drug currently being studied …
